GlassScriptPhysician profile
Douglas Michael Leone
NPI 1255523296
$7,411.20
in general payments reported to CMS, 2019-2025
36 companies · $486 in 2025
The $486 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,252 · 2020: $733 · 2021: $1,587 · 2022: $1,058 · 2023: $780 · 2024: $1,515 · 2025: $486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,001 · Grant: $590 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,000.65 |
| Grant | $590.00 |
| Education | $189.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,427.13 | 2019-2022 | |
| Abbvie INC. | $1,330.50 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $697.76 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $557.81 | 2019-2025 | Ilumya, Odomzo, Blu-U |
| Janssen Biotech, INC. | $439.80 | 2019-2024 | Tremfya, Remicade, Stelara |
| Organogenesis INC. | $328.95 | 2019-2025 | Puraply Am, Cygnus Dual, Novachor |
| Lilly USA, LLC | $277.60 | 2019-2025 | Taltz, Ebglyss |
| Genzyme Corporation | $264.84 | 2019-2024 | |
| Pfizer INC. | $248.60 | 2019-2022 | |
| Leo Pharma INC. | $239.23 | 2021-2025 | Adbry, Anzupgo |
| Amgen INC. | $238.16 | 2019-2023 | Otezla |
| Regeneron Healthcare Solutions, INC. | $168.49 | 2019-2023 | Libtayo |
| Ucb, INC. | $167.61 | 2019-2024 | Bimzelx, Cimzia |
| Incyte Corporation | $148.27 | 2021-2025 | Opzelura |
| Genentech USA, INC. | $111.94 | 2019-2022 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Leone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.